Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and speech pathology for idiopathic and refractory chronic cough
ACTRN12611001186943Phase 3Completed
- Sponsor
- John Hunter Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in chronic idiopathic cough (CIC) and refractory chronic cough (RCC) (4 arms), sponsored by John Hunter Hospital. Primary endpoints: Cough quality of life at Week 18, Cough frequency at Week 18 and 1 more. Started Mar 2012; status: completed.
02
Drugs
pregabalin
03
Conditions
chronic idiopathic cough (CIC)refractory chronic cough (RCC)
Beyond the preview
Go deeper on ACTRN12611001186943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001186943.